# ImmuPharma PLC London Investor Evening 26 February 2018

- Link: https://www.directorstalkinterviews.com/immupharma-plc-london-investor-evening-26-february-2018/412745855
- Published: 2018-02-15T07:17:15+00:00
- Author: Giles Arbor

**ImmuPharma PLC** (LON:IMM), specialist drug discovery and development company,
has today announced that Tim McCarthy, Chairman, will be presenting at an investor
evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent
£10 million fundraise by ImmuPharma.

 

The proceeds of the Placing allow the Company to make investment into potential 
indications emanating from the Company’s P140 platform, in addition to lupus. The
Placing further strengthens the balance sheet and enhances ImmuPharma’s position
in ongoing and future negotiations with potential partners for Lupuzor™.

The event will be held on Monday 26th February 2018 in London, EC2 and will commence
at 6pm. Further details on the event will be provided upon registration. To Register
your interest, please email lisa.baderoon@immupharma.com and info@turnerpope.com
or call 0203 621 4120.

Share on:
